VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

EHA 2015 | Outlook for the management of chronic myeloid leukemia

The management of chronic myeloid leukemia remains a significant challenge despite the introduction of effective tyrosine kinase inhibitors. At the 20th Congress of the European Hematology Association (EHA), Stephen O’Brien, BSc (Hons), PhD, MBChB, FRCP, FRCPath, of the University of Newcastle, Newcastle upon Tyne, UK, explains possible new strategies that may improve the outlook for these patients.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter